Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States.

ABSTRACT:

Introduction

Alopecia areata (AA), an autoimmune disease, is characterized by non-scarring hair loss involving the scalp, face, and/or body. Prior to 2022, no US Food and Drug Administration (FDA)-approved treatments for AA were available in the USA; existing treatment options had limited efficacy and durability and are often associated with side effects. This study aimed to evaluate the current AA treatment patterns and treatment satisfaction as reported by dermatologists.

Methods

Real-world data from a 2019 cross-sectional survey of US dermatologists and their adult patients with AA were analyzed. Dermatologists provided comprehensive data on their patients with AA, including AA dermatologist-assessed severity, treatments, treatment duration, treatment satisfaction, and re

SUBMITTER: Fridman M 

PROVIDER: S-EPMC9618487 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature